The roots of the CHIP discovery go back to 2012, when several lines of evidence converged to implicate clonal hematopoiesis driven by somatic mutations in certain known leukemia driver genes as a harbinger of acute myeloid leukemia (AML). This evidence concerns the gene STUB1 and acute myeloid leukemia.